KemPharm Taking Ritalin Prodrug Into Phase III For ADHD
Executive Summary
Months after reaching agreement with FDA to refile the NDA for its abuse-deterrent opioid Apadaz, KemPharm has gotten the okay to take its prodrug of Ritalin into Phase III for ADHD.